Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-02-27 Sale | 2025-02-28 4:36 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 2,650 | $475.34 | $1,259,651 | 19,352 (Direct) | View |
2025-02-25 Sale | 2025-02-26 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,767 | $480.95 | $849,839 | 24,484 (Direct) | View |
2025-02-11 Sale | 2025-02-12 4:29 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,747 | $459.83 | $803,323 | 23,225 (Direct) | View |
2024-06-12 Sale | 2024-06-13 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 7,288 | $478 | $3,483,664 | 15,972 (Direct) | View |
2024-02-26 Sale | 2024-02-27 4:44 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 883 | $425.7 | $375,893 | 15,972 (Direct) | View |
2024-02-21 Sale | 2024-02-23 4:16 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,201 | $421.77 | $506,546 | 18,509 (Direct) | View |
2024-02-20 Sale | 2024-02-21 4:23 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 801 | $420.79 | $337,053 | 19,710 (Direct) | View |
2024-02-12 Sale | 2024-02-13 4:54 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 913 | $420.24 | $383,679 | 23,137 (Direct) | View |
2023-06-01 Sale | 2023-06-05 5:03 pm | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 6,250 | $17.91 | $111,938 | 0 (Direct) | View |
2023-03-01 Sale | 2023-03-03 5:18 pm | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 10,000 | $13.6 | $136,000 | 20,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-02-26 Tax Withholding | 2025-02-28 4:36 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 2,482 | $479.61 | 19,352 (Direct) | View |
2025-02-24 Tax Withholding | 2025-02-26 4:09 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,656 | $483.28 | 24,484 (Direct) | View |
2025-02-14 Tax Withholding | 2025-02-19 4:26 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,529 | $463.46 | 27,907 (Direct) | View |
2025-02-12 Option Award | 2025-02-14 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 6,211 | $0 | 29,436 (Direct) | View |
2025-02-10 Tax Withholding | 2025-02-12 4:29 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 876 | $467.98 | 23,225 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 9,876 | $0 | 25,848 (Direct) | View |
2025-02-03 Option Award | 2025-02-05 4:01 pm | N/A 2035-02-03 | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 56,400 | $0 | 56,400 (Direct) | View |
2024-06-11 Tax Withholding | 2024-06-13 4:09 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 6,824 | $481.96 | 15,972 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 14,112 | $0 | 30,084 (Direct) | View |
2024-02-23 Tax Withholding | 2024-02-27 4:44 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,654 | $431.79 | 15,972 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-21 4:23 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,125 | $420.58 | 19,710 (Direct) | View |
2024-02-16 Tax Withholding | 2024-02-21 4:23 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,501 | $424.01 | 19,710 (Direct) | View |
2024-02-09 Tax Withholding | 2024-02-13 4:54 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 832 | $422.74 | 23,137 (Direct) | View |
2024-02-06 Option Award | 2024-02-08 4:24 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 11,003 | $0 | 24,882 (Direct) | View |
2024-02-01 Option Award | 2024-02-05 8:15 pm | N/A 2034-02-01 | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 45,150 | $0 | 45,150 (Direct) | View |
Ownership | 2023-09-05 4:23 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 0 | $0 | 13,879 (Direct) | View |
2023-06-01 Exercise | 2023-06-05 5:03 pm | N/A N/A | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 6,250 | $2.61 | 0 (Direct) | View |
2023-06-01 Exercise | 2023-06-05 5:03 pm | N/A 2032-05-25 | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 6,250 | $0 | 0 (Direct) | View |
2023-03-01 Exercise | 2023-03-03 5:18 pm | N/A N/A | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 10,000 | $4.44 | 20,000 (Direct) | View |
2023-03-01 Exercise | 2023-03-03 5:18 pm | N/A 2032-02-16 | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 10,000 | $0 | 20,000 (Direct) | View |
2023-02-09 Option Award | 2023-02-13 5:33 pm | N/A 2033-02-09 | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 27,400 | $0 | 27,400 (Direct) | View |
2022-05-25 Option Award | 2022-05-27 4:15 pm | N/A 2032-05-25 | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 6,250 | $0 | 6,250 (Direct) | View |
Ownership | 2022-03-01 6:39 pm | N/A 2032-02-16 | 89bio Inc. | ETNB | Atkinson Edward Morrow III Director | 0 | $0 | 30,000 (Direct) | View |